4P Pharma’s CEO, Revital Rattenbach, and our business developer Luigi Formicola, will be attending the upcoming MEET2WIN Oncology Business convention in Bordeaux, May 11-12th 2017. 4P-Pharma develops innovative drugs notably in the oncology field. We partner with academic institutions, TTOs, and biotech/pharma companies, our adaptative collaborative on a co-share co-risk model. Contact us via the&hellip
4P-Pharma et PULSALYS établissent un accord de co-maturation pour le développement d’un médicament innovant dans le traitement du cancer 4P-Pharma, la société de recherche préclinique, spécialisée dans le développement de nouveaux médicaments et PULSALYS la Société d’Accélération du Transfert de Technologies de Lyon Saint-Etienne, ont conclu début février 2017 un accord de co-maturation avec&hellip
4P-Pharma participates in the 5th edition of Le Prix La Tribune Jeune Entrepreneur. Created in 2013, the La Tribune Young Entrepreneur Prize aims to reveal the most innovative young start ups from region to region in France. These entrepreneurs, representing the dynamism of the French Tech, are selected by La Tribune and a jury of partners.&hellip
4P-Pharma team will be attending the Longevity conference in Lille, France, on December 8-9. Come and meet us at our booth to talk about innovation, maturation program and co-development partnership! We hope to meet you there!
4P-Pharma is glad to participate in the Research and Innovation week in the Hauts-de-France. You can meet us at the innovation showroom organized by the bio incubator Eurasanté on november 23rd. We will be happy to present the company, our innovations and our ongoing partnerships. Looking forward to see you there! Eurasanté expose les innovations&hellip